Loading organizations...
§ Private Profile · San Francisco, CA, USA
CRM Co-Pilot for Medtech Sales
Obento Health has raised $500K across 1 funding round.
Key people at Obento Health.
Obento Health was founded in 2023 by Naxin Wang (Founder).
Obento Health has raised $500K in total across 1 funding round.
Obento Health is redefining the CRM experience for medical field sales. Designed specifically for healthcare, we are saving reps time from documentation and empowering reps to create more personalized interactions with their customers.
Obento Health has raised $500K across 1 funding round. Most recently, it raised $500K Seed in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2023 | $500K Seed | — | Y Combinator | Announced |
Key people at Obento Health.
Obento Health was founded in 2023 by Naxin Wang (Founder).
Obento Health has raised $500K in total across 1 funding round.
Obento Health's investors include Y Combinator.
Obento Health is a CRM co-pilot platform specifically designed to enhance medical device sales by streamlining customer relationship management for field representatives in the medtech sector. The company builds a mobile-first, AI-powered tool that saves sales reps time on administrative tasks like activity tracking and enables more personalized, efficient interactions with healthcare customers. By integrating seamlessly with existing CRM systems, Obento Health empowers medtech sales teams to increase productivity and gain strategic insights, ultimately improving sales outcomes and customer engagement[5].
Founded in 2023 and backed by Y Combinator, Obento Health serves medical device sales representatives and their management teams. It addresses the problem of inefficient, clunky CRM systems that consume valuable time and reduce sales effectiveness. The platform’s voice-to-CRM logging, enriched domain-specific data, and debrief modes help reps uncover critical insights and focus more on customer relationships rather than administrative overhead[2][5].
Obento Health was founded in 2023 by Naxin Wang and Rodrigo Gutierrez, who bring a combined 20 years of experience building products at the intersection of healthcare and consumer wellness. Naxin’s background includes product management at Verily (formerly Google Life Sciences), where he worked on healthcare software for biopharma and medtech companies. Rodrigo’s experience includes leading product engineering at Strava, a consumer wellness platform. Their shared insight into healthcare workflows and consumer product design inspired them to create a CRM tool tailored to the unique needs of medical device sales reps, addressing the inefficiencies they observed firsthand[1][5].
Early traction includes acceptance into Y Combinator’s Summer 2023 batch, signaling strong investor confidence and validation of the product’s market fit[2][5].
Obento Health rides the growing trend of AI and mobile-first solutions transforming traditional sales workflows, particularly in complex, regulated industries like medtech. The timing is favorable due to increasing digital transformation in healthcare sales and the need for more efficient, data-driven customer engagement tools. As medical device reps face pressure to maximize time with healthcare providers while managing complex product portfolios, Obento’s platform addresses a critical pain point, improving both rep productivity and patient outcomes indirectly through better product adoption.
By enhancing CRM usability and insights, Obento Health contributes to the broader ecosystem of healthcare innovation, bridging the gap between clinical expertise and commercial execution. Its focus on evidence-based, personalized engagement aligns with the healthcare industry's shift toward value-based care and precision medicine[1][5].
Looking ahead, Obento Health is poised to expand its footprint within medtech sales and potentially other healthcare verticals requiring specialized CRM solutions. Trends such as AI augmentation, voice interfaces, and integrated data analytics will continue to shape its product evolution. As healthcare sales teams increasingly adopt digital tools, Obento’s influence could grow, setting new standards for CRM usability and effectiveness in the sector.
The company’s success will likely hinge on scaling its user base, deepening AI capabilities, and expanding integrations with major CRM platforms. Its founders’ expertise and Y Combinator backing provide a strong foundation for navigating these challenges. Ultimately, Obento Health aims to transform medtech sales from a "necessary evil" into a strategic advantage, improving both commercial outcomes and patient care through smarter, more personalized engagement[5][1].
